Related Experiment Video
Updated: Jun 21, 2026
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
MMP/TIMP expression profiles in distinct lung disease models: implications for possible future therapies
Sissie Wong1, Maria G Belvisi, Mark A Birrell
1Respiratory Pharmacology Group, Airways Disease Section, Imperial College London, Faculty of Medicine, National Heart and Lung Institute, 1st Floor Room 102, Sir Alexander Fleming Building, South Kensington Campus, Exhibition Road, London SW72AZ, UK. sissie.wong@imperial.ac.uk
Background:
There is currently a vast amount of evidence in the literature suggesting that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are involved in the pathogenesis of inflammatory airways diseases, such as asthma and COPD. Despite this, the majority of reports only focus on single MMPs, often only in one model system. This study aimed to investigate the profile of an extensive range of MMP/TIMP levels in three different pre-clinical models of airways disease. These models each have a different and very distinct inflammatory profile, each exhibiting inflammatory characteristics that are similar to that observed in asthma or COPD. Since these models have their own characteristic pathophysiological phenotype, one would speculate that the MMP/TIMP expression profile would also be different.
Methods:
With the use of designed and purchased MMP/TIMP assays, investigation of rat MMP-2, 3, 714 and TIMP-14 mRNA expression was undertaken by Real Time PCR. The three rodent models of airways disease investigated were the endotoxin model, elastase model, and the antigen model.
Results:
Intriguingly, we demonstrated that despite the distinct inflammatory profile observed by each model, the MMP/TIMP expression profile is similar between the models, in that the same MMPs/TIMPs were observed to be generally increased or decreased in all three models. It could therefore be speculated that in a particular disease, it may be a complex network of MMPs, rather than an individual MMP, together with inflammatory cytokines and other mediators, that results in the distinct phenotype of inflammatory diseases, such as asthma and COPD.
Conclusion:
We believe our data may provide key information necessary to understand the role of various MMPs/TIMPs in different inflammatory airway diseases, and aid the development of more selective therapeutics without the side effect profile of current broad-spectrum MMP inhibitors.
Insights
Despite distinct inflammatory profiles, matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) showed similar expression patterns across three preclinical airway disease models, suggesting a complex network is involved in pathogenesis.
Area of Science:
- Biomedical research
- Respiratory medicine
- Molecular biology
Background:
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are implicated in inflammatory airways diseases like asthma and COPD.
- Existing research often examines single MMPs in limited model systems.
- A comprehensive analysis of MMP/TIMP profiles across diverse preclinical models is lacking.
Purpose of the Study:
- To investigate the expression profiles of a wide range of MMPs and TIMPs.
- To compare these profiles across three distinct preclinical models of airways disease.
- To understand the role of MMPs/TIMPs in the pathogenesis of asthma and COPD.
Main Methods:
- Utilized designed and purchased MMP/TIMP assays.
- Quantified mRNA expression of specific rat MMPs (MMP-2, 3, 7, 14) and TIMPs (TIMP-1, 4) using Real-Time PCR.
- Employed three rodent models: endotoxin, elastase, and antigen-induced airway inflammation.
Main Results:
- Despite differing inflammatory characteristics, all three models exhibited similar MMP/TIMP expression trends (general increases or decreases).
- This suggests a coordinated network of MMPs/TIMPs, rather than individual enzymes, contributes to disease phenotypes.
- The findings challenge the focus on single MMPs in disease research.
Conclusions:
- The study provides crucial insights into the complex roles of MMPs/TIMPs in various inflammatory airway diseases.
- Findings may guide the development of targeted therapeutics with improved side effect profiles compared to broad-spectrum inhibitors.
- Understanding the MMP/TIMP network is essential for advancing treatments for asthma and COPD.